mRNA |
Vandetanib |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.6 |
mRNA |
BX-912 |
GDSC1000 |
pan-cancer |
AAC |
-0.017 |
0.6 |
mRNA |
BRD-K99584050 |
CTRPv2 |
pan-cancer |
AAC |
-0.03 |
0.6 |
mRNA |
leptomycin B |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.6 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
NG-25 |
GDSC1000 |
pan-cancer |
AAC |
-0.016 |
0.6 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.6 |
mRNA |
SB 505124 |
GDSC1000 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.6 |
mRNA |
SCH-529074 |
CTRPv2 |
pan-cancer |
AAC |
-0.021 |
0.6 |